Wei Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Wanyu Shi
College of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding 071001, China
3 shared publications - Xiao Wang
College of Veterinary Medicine, Hebei Agricultural University, Baoding 071001, China
3 shared publications Ying Liu
College of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China
3 shared publicationsQianhui Zhao
College of Traditional Chinese Veterinary Medicine
2 shared publicationsYulan Jiao
College of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding 071000, China; Hebei Provincial Veterinary Biotechnology Innovation Center, Baoding 071000, China; Ringpu (Baoding) Biological Pharmaceutical Co., Ltd, Baoding 071031, China
2 shared publicationsChang Rong
College of Traditional Chinese Veterinary Medicine, Hebei Agricultural University, Baoding, 071001, China
1 shared publication
Latest Publications
- 31 December 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (2) , 1152-1163
Chinese Yam Polysaccharide-Loaded Aluminum Hydroxide Nanoparticle-Stabilized Pickering Emulsion as an Adjuvant to Enhance Immune Responses for the H9N2 Vaccine
Adjuvants, as vital components of vaccines, possess the capacity to augment the intensity, breadth, and persistence of immune responses. Traditional alum adjuvants are incapable of inducing Th1 cellular immunity. To enhance the efficacy and alter the type of immune responses triggered by alum adjuvants, we constructed a Pickering emulsion platform stabilized by Chinese yam polysaccharide-loaded aluminum hydroxide nanoparticles (C-AlPE). The Chinese yam polysaccharide (CYP) was utilized as the immunopotentiator, and the aluminum hydroxide nanoparticles (Al NPs) loaded with CYP were employed as solid nanoparticle stabilizers. The C-AlPE as an adjuvant for the H9N2 vaccine elicited a robust humoral immune response. Compared to commercial Algel adjuvant and ISA206 adjuvant, the C-AlPE adjuvant obviously promoted the generation of CD4+ and CD8+ T cells and increased the production of Th1- and Th2-type cytokines, thereby stimulating a balanced Th1/Th2 immune response. In addition, the C-AlPE adjuvant exhibited great biosafety in vivo against the H9N2 vaccine. RNA-seq analysis of the spleen indicated that the C-AlPE adjuvant modulated complex signaling pathways, thereby activating innate immune responses and subsequently adaptive immune responses. Our findings highlighted the considerable potential of C-AlPE as a safe and effective vaccine adjuvant, providing valuable insights for the development of novel polysaccharide- and alum-based adjuvants in a Pickering emulsion formulation, with potential applications in veterinary vaccines.
- 31 December 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (2) , 1152-1163
Chinese Yam Polysaccharide-Loaded Aluminum Hydroxide Nanoparticle-Stabilized Pickering Emulsion as an Adjuvant to Enhance Immune Responses for the H9N2 Vaccine
Adjuvants, as vital components of vaccines, possess the capacity to augment the intensity, breadth, and persistence of immune responses. Traditional alum adjuvants are incapable of inducing Th1 cellular immunity. To enhance the efficacy and alter the type of immune responses triggered by alum adjuvants, we constructed a Pickering emulsion platform stabilized by Chinese yam polysaccharide-loaded aluminum hydroxide nanoparticles (C-AlPE). The Chinese yam polysaccharide (CYP) was utilized as the immunopotentiator, and the aluminum hydroxide nanoparticles (Al NPs) loaded with CYP were employed as solid nanoparticle stabilizers. The C-AlPE as an adjuvant for the H9N2 vaccine elicited a robust humoral immune response. Compared to commercial Algel adjuvant and ISA206 adjuvant, the C-AlPE adjuvant obviously promoted the generation of CD4+ and CD8+ T cells and increased the production of Th1- and Th2-type cytokines, thereby stimulating a balanced Th1/Th2 immune response. In addition, the C-AlPE adjuvant exhibited great biosafety in vivo against the H9N2 vaccine. RNA-seq analysis of the spleen indicated that the C-AlPE adjuvant modulated complex signaling pathways, thereby activating innate immune responses and subsequently adaptive immune responses. Our findings highlighted the considerable potential of C-AlPE as a safe and effective vaccine adjuvant, providing valuable insights for the development of novel polysaccharide- and alum-based adjuvants in a Pickering emulsion formulation, with potential applications in veterinary vaccines.
- Open Access
- 12 December 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 249, 114428
Salvia miltiorrhiza polysaccharides alleviate florfenicol-induced inflammation and oxidative stress in chick livers by regulating phagosome signaling pathway
- 12 December 2022
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 249, 114428
Open AccessSalvia miltiorrhiza polysaccharides alleviate florfenicol-induced inflammation and oxidative stress in chick livers by regulating phagosome signaling pathway
- Open Access
- 27 August 2022
- Published by Elsevier in Poultry Science
- Vol. 101 (11) , 102152
Florfenicol induced renal inflammatory response and apoptosis via cell adhesion molecules signaling pathway
- 27 August 2022
- Published by Elsevier in Poultry Science
- Vol. 101 (11) , 102152
Open AccessFlorfenicol induced renal inflammatory response and apoptosis via cell adhesion molecules signaling pathway
- Open Access
- 2 June 2022
- Published by Elsevier in Poultry Science
- Vol. 101 (9) , 101989
Salvia miltiorrhiza polysaccharides alleviates florfenicol-induced liver metabolic disorder in chicks by regulating drug and amino acid metabolic signaling pathways
- 2 June 2022
- Published by Elsevier in Poultry Science
- Vol. 101 (9) , 101989
Open AccessSalvia miltiorrhiza polysaccharides alleviates florfenicol-induced liver metabolic disorder in chicks by regulating drug and amino acid metabolic signaling pathways